With the amazing research being made in the myeloma field, there are now more front-line therapies than ever. What are your options? How does your doctor determine which induction therapy is right for you? Join Dr. Diamond as he walks us through this complex decision.
Audrey joined the HealthTree Foundation as the Myeloma Community Program Director in 2020. While not knowing much about myeloma at the start, she has since worked hard to educate herself, empathize and learn from others' experiences. She loves this job. Audrey is passionate about serving others, loves learning, and enjoys a nice mug of hot chocolate no matter the weather.
Dr. Diamond is a hematologist/oncologist who specializes in the treatment of plasma cell disorders including monoclonal gammopathy of undetermined significance, smoldering myeloma, and multiple myeloma. His research interests include utilization of minimal residual disease (MRD)-guided approaches to clinical decision-making, maintenance therapy, and the genomics of multiple myeloma and secondary malignancies that occur in patients treated for multiple myeloma. He completed fellowship at Memorial Sloan Kettering Cancer Center, spending a year as chief fellow, and has just recently joined the myeloma group at Sylvester Comprehensive Cancer Center where he is now a member of the Myeloma Genomics Laboratory participating in translational research. Some of his current projects include: Characterizing the genomics and origin of therapy-related myelodysplastic syndromes and acute leukemias that develop post-melphalan treatment. An investigation of commonalities between rare structural variants seen in multiple myeloma at diagnosis and relapse; including real world data collected by HealthTree.
Thank you for your interest in the event. If you have any questions, we would love to help!
Feel free to give us a call or send us a message below.
+1 800 709 1113